Weight loss depends on the medication, the dose, consistency, metabolism, nutrition, activity, and how closely follow-up care is maintained
It is taken once a week at the same time and day
In December 2024, the FDA approved Zepbound (tirzepatide) for moderate-to-severe obstructive sleep apnea in adults with obesity, used alongside a reduced-calorie diet and more physical activity
This represents a staggering threefold increase since 2019 as more people recognize Semaglutides impact on weight loss and diabetes management (Source: Pew Research Center)
Clinical trials have demonstrated that semaglutide can reduce hemoglobin A1c by approximately 1.0-1.5% in patients with type 2 diabetes (with effects varying by dose and population) and produce weight loss of 10-15% of body weight when used at higher doses for obesity management